image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Babcock - CMD highlights huge defence opportunities; terrific chart

April 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • BAB
  • Price:
  • 508p
They say “history never repeats itself but it often rhymes,” which means details change, circumstances change, settings change and names change but similar events will eventually recycle. Former President Reagan was lampooned for his bad memory when Cold War fears of a nuclear holocaust were very real. Fast forward four decades and concerns of a nuclear conflagration from Ukraine have again bubbled to the surface with President “Sleepy Joe” Biden at the wheel and President Putin threatening “civilisation’s destruction” on the “declining” West. With the isolationist Donald Trump poised for re-election and NATO countries scrambling to ramp up military spend, shares in TMI favourite Babcock (already in Trader Portfolio 2) have finally caugh ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author